These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Long term experience of salazopyrin EN in rheumatoid arthritis (RA). Farr M; Bacon PA; Coppock J; Scott DL Scand J Rheumatol Suppl; 1987; 64():37-47. PubMed ID: 2893451 [TBL] [Abstract][Full Text] [Related]
4. Neutropenia in patients with rheumatoid arthritis, treated with sulphasalazine. Marouf ES; Morris IM Br J Rheumatol; 1990 Oct; 29(5):407-9. PubMed ID: 1977490 [No Abstract] [Full Text] [Related]
5. Fatal neutropenic enterocolitis associated with sulphasalazine therapy for rheumatoid arthritis. Chakravarty K; Scott DG; McCann BG Br J Rheumatol; 1992 May; 31(5):351-3. PubMed ID: 1349846 [TBL] [Abstract][Full Text] [Related]
6. [Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis]. Mundo A; Pedone V; Lamanna G; Cervini C Clin Ter; 1997; 148(1-2):7-13. PubMed ID: 9377840 [TBL] [Abstract][Full Text] [Related]
7. The Chinese herbal remedy Tripterygium wilfordii Hook F in the treatment of rheumatoid arthritis. Ann Intern Med; 2009 Aug; 151(4):I-36. PubMed ID: 19687475 [No Abstract] [Full Text] [Related]
8. Long term outcome of treatment with sulphasalazine in rheumatoid arthritis. Situnayake RD; McConkey B Drugs; 1986; 32 Suppl 1():71-2. PubMed ID: 2877857 [No Abstract] [Full Text] [Related]
9. Comparisons of sulfasalazine to gold and placebo in the treatment of rheumatoid arthritis. Williams HJ J Rheumatol Suppl; 1988 Sep; 16():9-13. PubMed ID: 2903928 [TBL] [Abstract][Full Text] [Related]
10. Sulfasalazine in rheumatoid arthritis. A double-blind, placebo-controlled trial. Pinals RS; Kaplan SB; Lawson JG; Hepburn B Arthritis Rheum; 1986 Dec; 29(12):1427-34. PubMed ID: 2879544 [TBL] [Abstract][Full Text] [Related]
11. [Experience with sulphasalazine (salazopyrin) in the treatment of rheumatoid arthritis]. Winkler V Orv Hetil; 1986 Aug; 127(34):2073-4, 2079-80. PubMed ID: 2876405 [No Abstract] [Full Text] [Related]
12. [Sulfasalazine as an antirheumatism agent; a review of the literature]. van Riel PL; Nuver-Zwart HH; van de Putte LB; Gribnau FW Ned Tijdschr Geneeskd; 1988 Mar; 132(13):594-5. PubMed ID: 2896302 [No Abstract] [Full Text] [Related]
14. [New basic preparations with prolonged action in the treatment of rheumatoid arthritis]. Tumanova IG; Sigidin IaA Ter Arkh; 1987; 59(4):80-3. PubMed ID: 2884735 [TBL] [Abstract][Full Text] [Related]
15. Does gastrointestinal adverse drug reaction influence therapeutic effect in the treatment of rheumatoid arthritis? Jiang M; Zhao J; Lu A; Zha Q; He Y J Altern Complement Med; 2010 Feb; 16(2):143-4. PubMed ID: 20132037 [No Abstract] [Full Text] [Related]
16. Tolerability of enteric-coated sulphasalazine in rheumatoid arthritis: results of a co-operating clinics study. Donovan S; Hawley S; MacCarthy J; Scott DL Br J Rheumatol; 1990 Jun; 29(3):201-4. PubMed ID: 1972633 [TBL] [Abstract][Full Text] [Related]
17. Sulfasalazine induced immune thrombocytopenia in a patient with rheumatoid arthritis. Narayan N; Rigby S; Carlucci F Clin Rheumatol; 2017 Feb; 36(2):477-479. PubMed ID: 27778097 [TBL] [Abstract][Full Text] [Related]
18. Sulfasalazine in severe rheumatoid arthritis: a study to assess potential correlates of efficacy and toxicity. Martin L; Sitar DS; Chalmers IM; Hunter T J Rheumatol; 1985 Apr; 12(2):270-3. PubMed ID: 2863375 [TBL] [Abstract][Full Text] [Related]